David Darrigan v. the American Prospect, Inc., Maureen Tkacik, David Dayen, and Greg Hansen

CourtCourt of Appeals of Texas
DecidedAugust 21, 2025
Docket02-24-00061-CV
StatusPublished

This text of David Darrigan v. the American Prospect, Inc., Maureen Tkacik, David Dayen, and Greg Hansen (David Darrigan v. the American Prospect, Inc., Maureen Tkacik, David Dayen, and Greg Hansen) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
David Darrigan v. the American Prospect, Inc., Maureen Tkacik, David Dayen, and Greg Hansen, (Tex. Ct. App. 2025).

Opinion

In the Court of Appeals Second Appellate District of Texas at Fort Worth ___________________________ No. 02-24-00061-CV ___________________________

DAVID DARRIGAN, Appellant

V.

THE AMERICAN PROSPECT, INC., MAUREEN TKACIK, DAVID DAYEN, AND GREG HANSEN, Appellees

On Appeal from the 431st District Court Denton County, Texas Trial Court No. 23-7737-431

Before Sudderth, C.J.; Birdwell and Walker, JJ. Memorandum Opinion by Justice Birdwell MEMORANDUM OPINION

This case involves the Texas Citizens Participation Act (TCPA). See Tex. Civ.

Prac. & Rem. Code Ann. §§ 27.001–.011. Appellant David Darrigan sued The American

Prospect, Inc., Maureen Tkacik, David Dayen (collectively, Prospect), and Greg Hansen

for defamation following the publication of an article by Prospect. 1 Prospect and

Hansen filed TCPA motions to dismiss, and the trial court granted the motions and

awarded both attorney’s fees and sanctions. Darrigan contends that both the dismissal

under the TCPA and the award of attorney’s fees and sanctions were error. Because we

will conclude that Darrigan did not establish by clear and specific evidence a prima facie

case as to each of his claims, we will hold that Prospect and Hansen were entitled to a

dismissal under the TCPA and that the trial court did not err in awarding attorney’s fees

and sanctions.

I. Background

In 2019, American Physician Partners (APP) purchased an emergency room (ER)

staffing company where Darrigan was employed. After the sale, Darrigan served as a

regional medical director for APP, overseeing the staffing of hospital ERs. Darrigan’s

testimony is that he was against joining APP but continued to work there until March

1 Darrigan also alleged several other causes of action and theories of liability or recovery against all named defendants: tortious interference with prospective relationships, business disparagement, negligence, intentional infliction of emotional distress, conspiracy, ratification, and aiding and abetting.

2 2023. 2 Following his resignation from APP, Darrigan started a new management

company called Elite Hospital Partners (Elite). According to Darrigan, he then began

discussions with several hospitals to have Elite take over their ER staffing.

On July 29, 2023, The American Prospect, Inc. published an article (the Article)

written by Tkacik, detailing the fall of APP: “Shock Treatment in the Emergency Room:

The Lehman-like collapse of a(nother) private equity-owned ER operator has

physicians calling louder than ever for a strike.” According to the Article, APP staffed

approximately 135 hospital ERs and “freestanding” ERs in 18 states. Tkacik stated in

the Article that she spoke with seven emergency room physicians, and they told her that

it was common for “ownership transitions” to occur but that this was “unlike anything”

they had experienced before.

In early July 2023, APP told physicians that the company was being acquired by

another company, and then on July 17, APP claimed that the “deal . . . was off” and

that it no longer had the liquidity to continue operations. When the Article was first

published less than two weeks later, APP had not yet filed for bankruptcy, and multiple

rumors were circulating that physicians may not be paid for work done in June or July.

The Article detailed additional issues stemming from APP’s collapse, such as the lack

of sponsorship of work visas for international clinicians and the loss of malpractice

insurance.

2 Emails Darrigan’s attorney sent to Tkacik stated that Darrigan resigned on June 5, 2023.

3 Along with those issues, the Article indicated that, because APP’s collapse had

abrogated its physician contracts, some hospitals and mega-practices had begun to

exploit the ensuing panic, inducing doctors to sign new contracts without negotiations.

Tkacik shined a spotlight on APP’s three founders and concluded that APP was a victim

of its own unprofessionalism and “frat house culture.” After discussing APP’s three

founders, Tkacik made several statements about Darrigan.

The Article reported that Darrigan was one of APP’s “favored insiders” and

“rose through the ranks at the company despite a controversial side gig running two

cafés that sell drinks spiked with the mood-altering herbs known as kratom and kava.”3

3 The word “controversial” appears to be hyperlinked (it is underlined) in the printout of the Article filed with Darrigan’s petition, and allegedly the hyperlink opened to a five-page Word document with an unsigned letter to the American Board of Emergency Medicine (ABEM), detailing concerns about Darrigan’s ownership of kava cafés, the dangers of kava, delta-8 THC, and kratom, along with the author’s opinion that Darrigan’s “promotion” of the substances is “unbecoming of an ABEM member” and a physician.

Kava is “an Australasian shrubby pepper (Piper methysticum) from whose crushed root an intoxicating beverage is made; the dried rhizome and roots of the kava used especially as a dietary supplement chiefly to relieve stress and anxiety.” Kava, Merriam- Webster’s Online Dictionary, https://www.merriam-webster.com/dictionary/kava (last visited Aug. 12, 2025). “Kratom is a tropical tree native to Southeast Asia. Consumption of its leaves produces both stimulant effects (in low doses) and sedative effects (in high doses), and can lead to psychotic symptoms, and psychological and physiological dependence. Kratom leaves contain two major psychoactive ingredients (mitragynine and 7-hydroxymitragynine). These leaves are crushed and then smoked, brewed with tea, or placed into gel capsules.” See Drug Fact Sheet: Kratom (Apr. 2020), https://www.dea.gov/sites/default/files/2020-06/Kratom-2020_0.pdf; see also A.B. v. Tex. Dep’t of Fam. and Protective Servs., No. 03-22-00759-CV, 2023 WL 3235814, at *3 n.5 (Tex. App.—Austin May 4, 2023, no pet.) (mem. op.) (recounting testimony concerning

4 This was followed by a parenthetical indicating that a kava bar franchisor had sued

Darrigan “for stealing its trade secrets.” According to the Article, Darrigan’s “upstart

ER practice” had “recently secured” a former APP contract to staff Comanche County

Memorial Hospital (CCMH) in Oklahoma. Immediately following this statement, a

source commented that “such ‘insider deals’ [had] led some physicians to suspect the

desire to discreetly award plum contracts to company ‘favorites’” may have been

responsible for APP’s delayed bankruptcy filing.

The day after the Article was published, Darrigan’s attorney, Adam Allen,

emailed Tkacik to “clear up the [inaccurate] reporting” in the Article. According to

Allen, Darrigan had first sued franchisor Kava Culture in April 2023 for “fraudulent

inducement[] and violations of many consumer protection statutes and . . . a few

criminal statutes.” Darrigan’s lawsuit was still pending when the Article was published.

Allen claimed that Kava Culture then “responded” to Darrigan’s lawsuit with one of its

own, claiming that Darrigan stole trade secrets. Allen also explained that Kava Culture’s

lawsuit had been dismissed in May 2023, but Kava Culture had refiled in a Florida state

father’s drug use in termination proceed, including positive drug test for kratom, which described kratom as a substance with “opioid-like effects” that in higher doses is mind- altering).

5 court a week later. The email requested that Tkacik include “these facts as an update to

[her] article.”4 Tkacik and Allen also spoke on the phone about the Article.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Robert C. White v. Fraternal Order of Police
909 F.2d 512 (D.C. Circuit, 1990)
Forbes Inc. v. Granada Biosciences, Inc.
124 S.W.3d 167 (Texas Supreme Court, 2003)
Low v. Henry
221 S.W.3d 609 (Texas Supreme Court, 2007)
Unifund CCR Partners v. Villa
299 S.W.3d 92 (Texas Supreme Court, 2009)
Garcia v. Gomez
319 S.W.3d 638 (Texas Supreme Court, 2010)
Joseph E. Hancock v. Easwaran P. Variyam
400 S.W.3d 59 (Texas Supreme Court, 2013)
Butnaru v. Ford Motor Co.
84 S.W.3d 198 (Texas Supreme Court, 2002)
EI Du Pont De Nemours & Co. v. Robinson
923 S.W.2d 549 (Texas Supreme Court, 1996)
LeBlanc v. Lamar State College
232 S.W.3d 294 (Court of Appeals of Texas, 2007)
Provencio v. Paradigm Media, Inc.
44 S.W.3d 677 (Court of Appeals of Texas, 2001)
Bentley v. Bunton
94 S.W.3d 561 (Texas Supreme Court, 2002)
Gray v. HEB Food Store 4
941 S.W.2d 327 (Court of Appeals of Texas, 1997)
Reardon v. Lightpath Technologies, Inc.
183 S.W.3d 429 (Court of Appeals of Texas, 2005)
Markel Insurance Co. v. Muzyka
293 S.W.3d 380 (Court of Appeals of Texas, 2009)
New Times, Inc. v. Isaacks
146 S.W.3d 144 (Texas Supreme Court, 2004)
Means v. ABCABCO, INC.
315 S.W.3d 209 (Court of Appeals of Texas, 2010)
Williams v. Conroe Independent School District
809 S.W.2d 954 (Court of Appeals of Texas, 1991)
Arthur Andersen & Co. v. Perry Equipment Corp.
945 S.W.2d 812 (Texas Supreme Court, 1997)
Downer v. Aquamarine Operators, Inc.
701 S.W.2d 238 (Texas Supreme Court, 1985)
Owens-Corning Fiberglas Corp. v. Malone
972 S.W.2d 35 (Texas Supreme Court, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
David Darrigan v. the American Prospect, Inc., Maureen Tkacik, David Dayen, and Greg Hansen, Counsel Stack Legal Research, https://law.counselstack.com/opinion/david-darrigan-v-the-american-prospect-inc-maureen-tkacik-david-dayen-texapp-2025.